Eslicarbazepine: systemic exposure to antiepileptic drugs is increased in patients with mild-to-moderate renal impairment. The dose of eslicarbazepine should be reduced in patients with a ...

Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the powerful anesthetic ketamine can save patients from prolonged, life-threatening ...

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...